Stocktoria

PRO DEX INC PDEX

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1994-05-31 · LEI

PRO DEX INC financials (annual)

Revenue
$21.9M $22.5M $27.2M $34.8M $38.0M $42.0M $46.1M $53.8M $66.6M $77.5M 2017201820192020202120222023202420252026
Net income
$5.1M $1.6M $4.1M $6.1M $6.2M $4.6M $7.1M $2.1M $9.0M $13.7M 2017201820192020202120222023202420252026
Free cash flow
$1.9M $4.4M -$3.8M -$2.5M -$2.9M $6.8M 2017201820192020202120222023202420252026

Bars are annual figures from 2017 to 2026; red bars are negative (a loss or cash outflow).

MetricFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue$77.5M$66.6M$53.8M$46.1M$42.0M$38.0M$34.8M$27.2M$22.5M$21.9M
Gross profit$24.3M$19.5M$14.6M$12.7M$13.1M$13.6M$13.1M$9.8M$7.9M$7.2M
R&D expense$3.3M$3.6M$3.2M$2.8M$3.0M$4.4M$2.3M$1.9M$1.9M$1.2M
SG&A expense$8.0M$5.2M————————
Operating income$13.0M$10.7M$7.2M$5.8M$5.1M$4.5M$7.1M$5.0M$2.4M$2.7M
Interest expense———$533,000$464,000$352,000$236,000$220,000$7,000$12,000
Income tax$4.4M$3.1M$507,000$2.4M$1.1M$1.4M$1.8M$1.3M$989,000-$2.1M
Net income$13.7M$9.0M$2.1M$7.1M$4.6M$6.2M$6.1M$4.1M$1.6M$5.1M
EPS (diluted)$4.12$2.67$0.60$1.95$1.21$1.57$1.50$0.97$0.37$1.25
Operating cash flow$7.2M-$1.7M$6.2M$5.5M-$847,000-$2.1M$4.9M$3.3M$3.1M$3.2M
Free cash flow$6.8M-$2.9M——-$2.5M-$3.8M$4.4M$1.9M——
Cash & equivalents$8.2M$419,000$2.6M$2.9M$849,000$3.7M$6.4M$7.7M$5.2M$4.2M
Inventory$21.5M$22.2M$15.3M$16.2M$12.7M$8.4M$8.2M$6.2M$4.4M$3.1M
Total assets$74.5M$61.2M$52.5M$51.8M$49.1M$40.3M$31.1M$25.5M$19.9M$16.4M
Total liabilities$26.9M$24.6M$21.6M$20.2M$23.7M$20.2M$12.1M$8.5M$2.6M$2.6M
Shareholders' equity$47.6M$36.6M$30.9M$31.6M$25.4M$21.1M$19.1M$17.0M$17.3M$13.7M

Growth · year-over-year · Revenue CAGR 15.1%

MetricFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue growth+16.5%+23.7%+16.8%+9.6%+10.5%+9.2%+28.2%+21.0%+2.4%+8.9%
Net income growth+52.2%+322.1%-69.9%+54.7%-25.9%+0.9%+47.3%+155.9%-68.1%+518.5%
EPS growth+54.3%+345.0%-69.2%+61.2%-22.9%+4.7%+54.6%+162.2%-70.4%+525.0%
Free cash flow growth—————-186.9%+128.3%———

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.